Daam1 (NM_026102) Mouse Tagged ORF Clone Lentiviral Particle
CAT#: MR211599L3V
- LentiORF®
Lenti ORF particles, Daam1 (Myc-DDK-tagged) - Mouse dishevelled associated activator of morphogenesis 1 (Daam1), transcript variant 1, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 16,055.00
货期*
详询
规格
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | Daam1 (NM_026102) Mouse Tagged ORF Clone Lentiviral Particle |
Synonyms | 1700066F09Rik; 2310028E21Rik; AI503486; E130308H01; mKIAA0666 |
Vector | pLenti-C-Myc-DDK-P2A-Puro |
ACCN | NM_026102 |
ORF Size | 3231 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(MR211599).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_026102.2, NP_080378.2 |
RefSeq Size | 6004 bp |
RefSeq ORF | 3234 bp |
Locus ID | 208846 |
Gene Summary | Binds to disheveled (Dvl) and Rho, and mediates Wnt-induced Dvl-Rho complex formation. May play a role as a scaffolding protein to recruit Rho-GDP and Rho-GEF, thereby enhancing Rho-GTP formation. Can direct nucleation and elongation of new actin filaments (By similarity). Involved in building functional cilia. Involved in the organization of the subapical actin network in multiciliated epithelial cells (By similarity). Together with DAAM2, required for myocardial maturation and sarcomere assembly (PubMed:26526197).[UniProtKB/Swiss-Prot Function] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...